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Bacteriocin Gene-Trait matching 
across the complete Lactobacillus 
Pan-genome
Fergus W. J. Collins1,2,3, Paula M. O’Connor1,2, Orla O’Sullivan  1,2, Beatriz Gómez-Sala1, Mary 
C. Rea1,2, Colin Hill2,3 & R. Paul Ross1,2,3
Lactobacilli constitute a large genus of Gram-positive lactic acid bacteria which have widespread 
roles ranging from gut commensals to starters in fermented foods. A combination of in silico and 
laboratory-based screening allowed us to determine the overall bacteriocin producing potential of 
representative strains of each species of the genus. The genomes of 175 lactobacilli and 38 associated 
species were screened for the presence of antimicrobial producing genes and combined with screening 
for antimicrobial activity against a range of indicators. There also appears to be a link between the 
strains’ environment and bacteriocin production, with those from the animal and human microbiota 
encoding over twice as many bacteriocins as those from other sources. Five novel bacteriocins were 
identified belonging to differing bacteriocin classes, including two-peptide bacteriocins (muricidin and 
acidocin X) and circular bacteriocins (paracyclicin). In addition, there was a clear clustering of helveticin 
type bacteriolysins in the Lactobacillus acidophilus group of species. This combined in silico and in 
vitro approach to screening has demonstrated the true diversity and complexity of bacteriocins across 
the genus. It also highlights their biological importance in terms of communication and competition 
between closely related strains in diverse complex microbial environments.
Bacteriocins are ribosomally-synthesised antimicrobial peptides which generally act by inducing pore formation 
or inhibiting cell wall synthesis in target cells1. Some bacteriocins such as nisin have found widespread applicabil-
ity as bio preservatives in food systems where they have been used for decades. Moreover, bacteriocin production 
can also be a key probiotic trait2, 3, and bacteriocins have been suggested as potential alternatives to antibiotics in 
the future4. The Lactobacillus genus has a long association with bacteriocin production, with numerous bacterioc-
ins isolated from such species5–7. Originally bacteriocin producers were isolated from functional screens against 
selected target strains, but many studies now rely on prior in silico screening, using tools such as BAGEL8, 9. 
BAGEL scans the bacterial genome for putative bacteriocin open reading frames (ORFs) and also analyses sur-
rounding ORFs to search for possible biosynthetic genes, immunity genes and transporters10. Whilst the areas of 
interest identified by BAGEL represent potential bacteriocin operons, this does not always translate into func-
tional bacteriocin production for many reasons including problems with mutation, regulation or target specificity.
There are varying accounts on the extent of bacteriocin production in the environment. While numerous 
accounts assume ubiquity in production11, 12, a definitive analysis has yet to focus on clarifying the actual extent 
of bacteriocin production. In this study, we elucidate the bacteriocinogenic potential of representative species 
of the Lactobacillus genus and some related genera; i.e. the Lactobacillus Genus Complex. Previously Sun et al.13 
analysed the genomes of 175 Lactobacillus species and 38 closely related species, carrying out a screen for putative 
bacteriocin operons using the BAGEL bacteriocin mining tool. Despite no longer formally being considered as 
bacteriocins, large (>30 kDa) helveticin-like antimicrobial proteins were also included in the study. Based on 
those results, we analysed strains which were identified as encoding putative bacteriocin operons for in vitro 
production using well diffusion assays (WDAs) and MALDI TOF MS. Well diffusion assays were used to detect 
antimicrobial production whilst MALDI TOF MS and SDS PAGE were used to identify the masses of the bacte-
riocins. Peptide masses identified by MS were correlated with the theoretical masses of bacteriocins identified by 
BAGEL to confirm the identity of the antimicrobial. We reinforced the BAGEL results with BLAST searches for 
key lantibiotic and sactibiotic enzymes using specific sequences employed in previous studies against this new 
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dataset of Lactobacillus genomes8, 14, 15. This redundancy allows for a more comprehensive analysis of bacteriocin 
gene clusters in the sequenced strains.
Results
Distribution of Bacteriocin Operons. Several studies have completed bacteriocin screens on diverse and 
unrelated species of bacteria8, 16, 17. The aim of this study was to focus primarily on the lactobacilli and investigate 
the distribution of bacteriocin genes across this single large important genus. From the information identified by 
BAGEL, we used a phylogenetic tree to visualise the distribution of bacteriocin operons within the genus (Fig. 1). 
Historically the Lactobacillus genus has a long association with bacteriocin production. While this study focuses 
on the type strain of each Lactobacillus species, Table 1 identifies those bacteriocins which have been previously 
identified and characterised from all strains in the Lactobacillus Genus Complex. In all, 66 bacteriocins have been 
characterised from lactobacilli previously, which would suggest a high degree of production within the genus. It 
is notable that the production of these unique bacteriocins is, in fact, restricted to 16 different species.
Visualisation of the distribution of bacteriocins throughout the Lactobacillus Genus Complex shows that there 
is a clear clustering of helveticin-like operons amongst the L. acidophilus branch of species, indicating that such 
genes have been retained from a common ancestor (Fig. 1). Despite being previously classified as class III bac-
teriocins, these proteins are now termed bacteriolysins and are considered a distinct group of antimicrobials. 
Whilst these proteins are ribosomally synthesised, they are much larger than classical bacteriocins (~30 kDa) and 
are heat labile. Helveticin J is the only member previously characterised18, but here we show that these genes are 
actually highly prevalent in the lactobacilli, with 43 potential homologs identified from 23 strains (for alignment 
results see Supplementary Figure 1). Of the 18 strains in the L. acidophilus group, 36 helveticin homologs were 
distributed amongst 16 of these strains. While certain strains can encode up to four helveticin homologs, there is 
insufficient homology between those to suggest recent gene duplications. The high degree of homology (in some 
cases greater than 99%) between some structural genes encoded by different strains does indicate that horizontal 
gene transfer of helveticin homologs has occurred; such a mechanism may also explain the presence of these 
genes in the six strains outside of the L. acidophilus group (Fig. 1).
The environment from which these strains have been isolated also seems to correlate with their bacteriocino-
genic potential (Supplementary Table 1). For example, of the strains isolated from an animal or human origin 
37.5% were identified as encoding a complete bacteriocin or helveticin like operon in BAGEL or BLAST screens 
(21 of 56 strains). This value for strains isolated from non-animal source (food, plants, environmental and alco-
hol/wine products) displays an over two-fold reduction at 16.67% (25 of 150 strains). This result suggests that the 
bacteriocin production may prove to be a competitive advantage for strains from complex environments such as 
the microbiota of humans and animals.
Diversity of Bacteriocins Identified. Bacteriocins are a diverse and varied group of antimicrobials, 
which use different systems for bacteriocin modification, transport and immunity. In silico analysis allows us to 
determine which types of bacteriocins the lactobacilli can synthesise. To analyse the diversity of the bacterioc-
ins encoded by lactobacilli an in silico screen was first carried out on the genome of each strain followed by in 
vitro screening of each bacteriocin encoding strain to identify antimicrobial activity against a range of indicators 
(Table 2). MALDI TOF MS and SDS PAGE allowed us to determine the mass and subsequently the identity of the 
bacteriocins produced by the strains (Supplementary Figure 2). The bacteriocin classification scheme devised by 
Cotter et al.1, 4 was used to distinguish between the different classes of bacteriocins.
Class I. Class I bacteriocins are comprised of ribosomally synthesised, post-translationally modified bac-
teriocins (RiPPs)4. Originally restricted to lantibiotics, this class has now been extended to include other 
post-translationally modified bacteriocins such as sactibiotics.
Lantibiotics. Lantibiotics are a group of bacteriocins characterised by the presence of lanthionine and 
methyllanthionine bridges. Here, serine and threonine residues are converted to 2,3-didehydroalanine (Dha) 
and 2,3-didehydrobutyrine (Dhb), respectively, which then react with the thiol group found in cysteine residues, 
forming lanthionine or methyllanthionine thioether cross-links19. Currently three lantibiotics have been attrib-
uted to the Lactobacillus genus; lactocin S20, plantaricin C21 and the two peptide lantibiotic plantaricin W6.
The BAGEL screen of the Lactobacillus dataset identified three further lactobacilli encoding lantibiotic struc-
tural peptides (Table 3, Supplementary Table 2 displays these genes with the associated leader sequence). Of 
these, potential production was only identified in L. taiwanensis DSM 21401 which encodes a type I lantipeptide 
(a lantibiotic which doesn’t display antimicrobial activity), characterised by the presence of LanB and LanC mod-
ification enzymes. What is unusual about this peptide is the fact the structural gene is small compared to other 
lantipeptides, with the mature peptide predicted to contain only 14 amino acids. Despite a lack of demonstrated 
antibacterial activity against the range of indicators tested, MALDI TOF MS did identify a mass which correlates 
with the predicted mass of the mature lantipeptide. The lack of antimicrobial activity may simply imply that the 
indicator organisms tested were not sensitive, or that the putative lantipeptide has a signalling rather than a bac-
teriocidal role.
A further type I lantibiotic operon was identified by BAGEL in the strain L. amylovorus DSM 20531. This 
strain appears to encode a complete lantibiotic operon which contains the required modification enzymes and an 
ABC transporter. L. gastricus DSM 16045 was found to encode a Lan C homolog but a LanB homolog was absent 
from the operon which is necessary for initial dehydration of serine and threonine residues. The production of 
either of these bacteriocins was not detected in vitro.
Lantibiotic operons were also identified in some of the other genera studied. Pediococcus damnosus DSM 
20331 was found to encode a class II lantibiotic. This strain has previously been found to produce the partially 
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characterised lantibiotic pediocin PD-122. From genomic data used in this study, the sequence of the pediocin 
PD-1 gene has now been elucidated, showing a high similarity to the lantibiotic plantaricin C (PlnC)23. Due to the 
similarity between the two bacteriocins, pediocin PD-1 likely shares a common mode of action with PlnC whose 
activity has been shown to be as a result of the combination of pore formation and inhibition of lipid II synthe-
sis24. P. claussenii DSM 14800 was also shown to encode pediocin PD-1, however, this strain failed to display 
bacteriocin production. The Carnobacterium maltaromaticum strains DSM 20722 and DSM 20730 were also both 
Figure 1. Distribution of complete bacteriocin operons amongst the Lactobacillus Genus Complex (Adapted 
from Sun et al. 12 596).
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Bacteriocin Subclass Producing strain Origin
Class I
Plantaricin W (α and β) II Lactobacillus plantarum LMG 2379 Wine
Plantaricin C II L. plantarum LL441 Cabrales cheese
Lactocin Sa II L. sakei L45 Sausages
Pediocin PD-1 II Pediococcus damnosus NCFB1832 Lager Beer
Glycocin F Glycocin L. plantarum KW30 Fermented corn
Class II
Acidocin A IIa L. acidophilus TK9201 Fermented milk (starter)
Curvaticin L442 IIa L. curvatus L442 Greek fermented sausage
Curvaticin 13 IIa L. curvatus SB13 Sausages
Sakacin P (variant)b IIa L. curvatus LTH1174 Fermented meat
Plantaricin BM-1 IIa L. plantarum BM-1 Fermented meat
Plantaricin C19 IIa L. plantarum C19 Fermented cucumber
Plantaricin 423 IIa L. plantarum 423 Sorghum (beer)
Sakacin Pc IIa L. sakei LTH673 Cured meat
Sakacin Ad IIa L. sakei Lb706 Meat
Sakacin Ge IIa L. sakei 2512 Food origin
Sakacin Xf IIa L. sakei 5 Malt
Bavaricin A IIa L. sakei MI1401 Sourdough
Bavaricin MN IIa L. sakei MN Meat (bovine)
Bacteriocin L-1077 IIa L. salivarius L-1077 Intestine (broilers)
Leucocin Agh IIa Leuconostoc geldium UAL 187 Vacuum-packed meat
Leucocin C IIa Leuc. mesenteroides TA33a Spoiled vacuum-packed meat
Leucocin 10Ch IIa Leuc. mesenteroides 10 Malted barley
Leucocin 683Y IIa Leuc. mesenteroides 683 Malted barley
Mesentericin Y105 IIa Leuc. mesenteroides subsp. mesenteroides Y105 Goats milk
Pediocin PA-1 (ACH)i IIa P. acidilactici PAC1.0 Meat
Pediocin SA-1 IIa P. acidilactici NRRL B5627 Meat
Penocin A IIa P. pentosaceus ATCC 25745 Plants
Pediocin SM-1 IIa P. pentosaceus Mees 1934 Meat
Weissellin A IIa Weissella paramesenteroides DX Sausage
Lactobin Aj IIb L. amylovorus LMG P-13139 Corn liquor
Brevicin 174 (breB and breC) IIb L. brevis 174A Iyokan (fruit)
Lactocin 705 (Lac705α and Lac705β) IIb L. casei CRL 705 Meat
Acidocin LF221 (LF221A and LF221B)k IIb L. gasseri LF221 Faeces (child)
Gassericin T (GatA and GatX) IIb L. gasseri SBT2055 Faeces (human)
Lactacin F (LafA and LafX)l IIb L. johnsonii VPI11088 Intestine (human)
Bacteriocin Type/Subclass Producing strain Origin
Sakacin T (SakTα and SakTβ)m IIb L. sakei CTC372 Sausages
Plantaricin E/F (PlnE and PlnF) IIb L. plantarum C11 Fermented cucumber
Plantaricin J/K (PlnJ and PlnK) IIb L. plantarum C11 Fermented cucumber
Plantaricin S (Plsα and Plsβ)n IIb L. plantarum LPCO10 Green olives
Plantaricin NC8 (PLNC8α and PLNC8β) IIb L. plantarum NC8 Ensilage
Salivaricin ABP-118 (Abp118α and Abp118β) IIb L. salivarius UCC118 Intestine (human probiotic)
Salivaricin CLR 1328 (Salα and Salβ) IIb L. salivarius CLR1328 Vagina (human)
Salivaricin P (Sln1 and Sln2) IIb L. salivarius DPC6005 Intestine (pig)
Salivaricin T (SalTα and SalTβ) IIb L. salivarius DPC6488 Intestine (neonate)
Acidocin B IIc L. acidophilus M46 Food origin
Gassericin A° IIc L. gasseri LA39 Faeces (child)
Leucocyclicin Q IIc Leuc. mesenteroides TK41401 Japanese pickles
Acidocin 8912 IId L. acidophilus TK8912 Dairy origin
Brevicin 27 IId L. brevis SB27 Sausages
Lactocin MXJ 32 A IId L. coryniformis MXJ 32 Fermented vegetables
Curvalicin BAP2 IId L. curvatus CWBI-B28 Meat
Curvaticin FS47 IId L. curvatus FS47 Meat
Sakacin Q (variant)p IId L. curvatus LTH1174 Fermented meat
Continued
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found to encode the two-component lantibiotic carnolysin, however the in vitro production of this bacteriocin 
was not seen in either strain25.
To supplement the results of BAGEL searches, previous in silico lantibiotic screens were repeated on the new 
Lactobacillus dataset. We used the modification enzymes NisC, LtnM1 and VenL as drivers in the BLAST search 
for novel lantibiotics8, 14, 15. L. gallinarum DSM 10532, L. crispatus DSM 20584 and P. cellicola DSM 17757 were 
all found to harbour a NisC homolog, despite not being identified by BAGEL. However, upon examination of the 
surrounding genes, no potential structural genes were identified. Strains identified in BLAST searches as encod-
ing LanM homologs had also been identified by BAGEL. No homolog of the novel lanthionine synthase VenL was 
identified in the BLAST screen.
Bacteriocin Subclass Producing strain Origin
Bacteriocin SJ2-8 IId L. paracasei BGSJ2-8 Home-made cheese
Paracin C IId L. paracasei CICC 20241 Probiotic
Plantaricin 1.25 α IId L. plantarum TMW1.25 Fermented sausages
Plantaricin 1.25 β IId L. plantarum TMW1.25 Fermented sausages
Plantaricin 149 IId L. plantarum NRIC 149 Pineapple
Plantaricin 163 IId L. plantarum 163 Fermented vegetables
Plantaricin A IId L. plantarum C11 Fermented cucumber
Plantaricin ASM1 IId L. plantarum A-1 Corn bread
Plantaricin JLA-9 IId L. plantarum JLA-9 Suan-Tsai (Chinese fermented cabbage)
Plantaricin ST31 IId L. plantarum ST31 Sourdough
Sakacin Qq IId L. sakei LTH673 Fermented dry sausage
Salivaricin L IId L. salivarius DPC6488 Intestine (neonate)
Bacteriocin Type/ Subclass Producing strain Origin
Plantaricin Y IId L. plantarum 510 Koshu vineyard
Rhamnosin A IId L. rhamnosus 68 Intestinal microbiota (human)
Bactofencin A IId L. salivarius DPC6502 Intestine (porcine)
Bacteriocin LS2 IId L. salivarius BGHO1 Oral (human)
Leucocin B IId Leuc. mesenteroides TA33a Spoiled vacuum-packed meat
Mesentericin 52Br IId Leuc. mesenteroides FR52 Raw Milk
Leucocin N IId Leuc. pseudomesenteroides QU 15 Nukadoko
Leucocin Q IId Leuc. pseudomesenteroides QU 15 Nukadoko
Weissellicin 110 IId Weissella cibaria 110 Plaa-Som
Weissellicin L IId W. hellenica 4–7 Sian-sianzih
Weissellicin M IId W. hellenica QU 13 Pickel barrel
Weissellicin Y IId W. hellenica QU 13 Pickel barrel
Lactacin Bs — L. acidophilus N2 Food origin
Bacteriocin TSU4 — L. animalis TSU4 Intestine (fish)
Curvalicin BAP3 — L. curvatus CWBI-B28 Meat
Gassericin E — L. gasseri EV1461 Healthy vagina (human)
Plantacin B — L. plantarum NCDO1193 Dairy origin
Plantaricin F — L. plantarum BF001 Spoiled cat fish filets
Plantaricn T — L. plantarum LPCO10 Green olives
Bacteriocin SMXD51 — L. salivarius SMXD51 Faeces (chicken)
Salivaricin B — L. salivarius M7 Food origin
Bacteriolysin
Helveticin J L. helveticus NCDO481 Dairy origin
Table 1. Bacteriocins characterised from species within the Lactobacillus Genus Complex. Characterised 
bacteriocins with identical amino acid sequences: aSakacin M/lactocin S from L. sakei 148. bVariant of sakacin 
P from L. curvatus L442. cSakacin 674 from L. sakei 674. dCurvacin A from L. curvatus LTH1174 and sakacin 
K from L. sakei CTC 494 . eBacteriocin R1333 from Lb. sakei R1333. fSakacin X from L. curvatus 2711 and L. 
curvatus CRL705. gLeucocin A-TA33a from Leuonostoc mesenteroides TA33a, and Leucocin B-Ta11a from Leuc. 
carnosum Ta11a. hLeucocin A-4010 and Lecucocin B-4010 from Leuc. carnosum 4010. iAlso produced by L. 
plantarum WHE92. jAmilovorin L471 from L. amylovorus DCE471. kGassericin K7 (K7A y K7B) from L. gasseri 
K7. lLactacin F from L. acidophilus 30SC. mSakacin T (SakTα and SakTβ) from L. sakei 5, L. curvatus 2711 and 
L. curvatus CRL705. nAlso produced by L. pentosus B96. pReutericin 6 from L. reuteri LA6. pVarient of sakacin Q 
from L. curvatus L442 and L. curvatus CRL705. qSakacin Q from L. sakei Lb674 and sakacin Q from L. curvatus 
CRL705. rMesentericin B105 from Leuc. mesenteroides subsp. mesenteroides Y105. sAcidocin J1132 from L. 
acidophilus JCM1132.
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Sactibiotics. The sactibiotics are a growing class of bacteriocins characterised by the presence of unusual 
sulphur to α-carbon linkages. These modifications are carried out by radical S-adenosylmethionine (SAM) pro-
teins which catalyse the formation of these thioether bonds26, 27. To analyse the prevalence of potential sactibiotic 
operons within the lactobacilli, the sequences for the radical SAMs associated with a two-component sactibiotic 
thuricin CD (TrnC and TrnD) were used as drivers in a BLAST analysis of the genomes available17, 28. Only two 
radical SAMs were found resembling those associated with thuricin CD. L. mali DSM 20444 was found to encode 
one such SAM, however, analysis of the operon failed to identify a potential structural gene. Kandleria vitulina 
DSM 20405 appears to encode a complete sactibiotic operon, encompassing a structural gene, transporter and 
associated radical SAM, however, no biological activity could be attributed to this strain with the panel of indica-
tors tested. BAGEL further identified two potential sactibiotic related radical SAM proteins in C. maltaromaticum 
DSM 20342 and DSM 20722 but no potential structural gene for these enzymes was apparent.
TOMMs. Thiazole/oxazole modified microcins (TOMMs) are a class of RiPPs which are now included with 
the class I bacteriocins. These peptides undergo extensive post-translational modification, with the conversion of 
cysteine, serine and threonine residues into the corresponding heterocycles; thiazole, oxazole and methyloxazole, 
respectively29. TOMMs exist in gene clusters encoding several factors involved in transport, modification and 
immunity. Using streptolysin as an example, the modification of the structural peptide is the result of the activity 
of the SagBCD enzyme complex, encompassing a cyclodehydratase (SagC), a dehydrogenase (SagB) and a dock-
ing protein (SagD)30. Whilst SagBCD clusters are described as being relatively widespread amongst prokaryotes, 
no TOMM has yet been identified from a Lactobacillus species30. In our study L. crispatus DSM 20584, L. intesti-
nalis DSM 6629 and Oenococcus kitaharae DSM 17330 were identified by BAGEL as encoding homologs of the 
SagBCD gene cluster. Whilst the operons in O. kitaharae DSM 17330 and L. intestinalis DSM 6629 appear to be 
complete, the L. crispatus DSM 20584 TOMM operon appears to lack a structural gene, however, the structural 
gene for similar operons has been found to be some distance from the SagBCD homologs previously31. Of these 
three strains, L. crispatus DSM 20584 was the only one found to display antimicrobial activity; the source of such 
activity, however, remains unclear.
Species Strain Potential Unmodified Lantibiotic/Lantipeptide Sequence
L. taiwanensis DSM 21401 TSTGCCNGPSKLQG
L. amylovorus DSM 20531 AKSYSAYSSCSCVNPPCPIATMD
L. gastricus DSM 16045 GTETAQSTPAISRVTLSIARKSSAKCISWISFSAGGLNSYKSKC
P. damnosus 
(Pediocin PD-1) DSM 20331 KKIKKSSSGDICTLTSECDHLATWVCC
Table 3. Potential Lantibiotic/Lantipeptide Structural Peptides.
Bacteriocin Producers
Strain 
(DSM)
Activity of Bacteriocin Producers vs. Indicator Organisms*
L. delbrueckii 
subsp. 
bulgaricus
L. delbrueckii 
subsp. lactis L. amylovorus L. casei L. plantarum L. rhamnosus
Listeria 
innocua
Enterococcus 
saccharolyticus E. mundtii
L. paralimentarius 13961 ++ +++ ++ + +++
L. murinus 20452 +
L. hordei 19519 ++ ++ ++ +++ +++ +++
L. intestinalis 6629 +++ +
L. paracasei subsp. 
paracasei 5622 + +
L. acidophilus 20079 ++ ++ + +
L. agilis 20509 +
L. crispatus 20584 ++ + +
L. equicursoris 19284 ++
L. pentosus 20314 +
L. kalixensis 16043 +
L. amylovorus 20531 +
L. kitasatonis 16761 ++
P. damnosus 20331 +++
C. maltaromaticum 20342 + +
C. maltaromaticum 20722 ++ + + ++
Table 2. Spectrum of inhibition of bacteriocin producing strains against a range of indicator strains. Activity 
of pH neutralised cell free supernatants from bacteriocin producers in agar well diffusion assay. Inhibition of 
indicators is described in radius (mm) of the zone of inhibition in WDA, scores are as follows: + = 0.5–2 mm, 
++ = 2.5–5mm, +++ = >5 mm.
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Class II. Class II bacteriocins are small heat stable peptides which are not subject to extensive post transla-
tional modification, most of which act to permeabilize the membrane of target cells1. This class of bacteriocins is 
further subdivided based on the structure and activity of the peptides.
Class IIa. Class IIa or ‘pediocin-like’ bacteriocins display a narrow range of antimicrobial activity, particularly 
displaying strong anti-listerial activity. Such bacteriocins encompass a highly conserved YGNGV/L N-terminal 
motif followed by cysteine residues which can form a disulphide bridge. Unlike the N-terminus, the C-terminus 
is less conserved and is likely involved in membrane insertion and pore formation32. These bacteriocins likely act 
by using the mannose-phosphotransferase system on sensitive cells as a receptor33.
Despite having a long association with this class of bacteriocins, surprisingly only 3 Lactobacillus strains were 
found to encode what appear to be complete class IIa bacteriocin operons, containing structural, immunity and 
transport genes (Table 4a, Supplementary Table 2). Of these, L. hordei DSM 19519 displayed bacteriocin produc-
tion against six of the indicators tested. From MALDI TOF MS and BAGEL results, the production of coagulin 
was confirmed. This 44 amino acid bacteriocin was originally isolated from Bacillus coagulans and closely resem-
bles the bacteriocin pediocin PA-1, differing by a single amino acid due to a N41T substitution34, 35. The presence 
of a further pediocin-like operon was noted within the L. hordei genome, encoding a structural peptide displaying 
74% amino acid identity to plantaricin 423. Production of this bacteriocin however was not seen.
Numerous lactobacilli identified in this study were found to carry partial pediocin-like operons, often con-
taining the bacteriocin structural gene and associated immunity protein but lacking the appropriate transporters 
(Table 4b, Supplementary Table 2). One potential explanation is that when a strain acquired the gene for pediocin 
resistance that the neighbouring small bacteriocin structural gene was also transferred, whilst the larger trans-
porters were not.
Although not included in the Lactobacillaceae family, several Carnobacterium strains were included in the 
genomic study carried out by Sun et al.13. Numerous bacteriocins have been attributed to this genus previously25, 36. 
While the source of antimicrobial activity from C. maltaromaticum DSM20342 is unclear, C. maltaromaticum 
DSM 20722 was found to produce the class IIa bacteriocin cbnB2 and cbnBM1, the class IId bacteriocin cbnX was 
also produced by the strain25. CbnB2 contains an N2Y mutation which was also previously seen by Tulini et al.25.
Class IIb. Class IIb are comprised of unmodified two peptide bacteriocins, whose activity is dependent on 
the synergistic activity of both peptides which interact to form a single antimicrobial unit37. These bacteriocins 
are likely to act by forming membrane spanning pores which result in the leakage of small molecules from the 
cell. Such bacteriocins tend to contain conserved GxxxG or AxxxA motifs which are responsible for close helix 
interactions between each bacteriocin peptide37. A wide range of class IIb bacteriocins were identified by BAGEL 
in this study (Table 5, Supplementary Table 2).
L. murinus DSM 20452 was one of the strains which demonstrated bacteriocin production. MALDI TOF MS 
identified masses which correlate with a two-peptide bacteriocin identified by BAGEL (muricidin). Both peptides 
of muricidin display homology to the class IIa bacteriocin plantaricin S, with the α peptide displaying 41% amino 
Species Strain Structural Peptide
Homolog 
(%Amino Acid 
Identity)
(a) Structural Genes for Complete Class IIa Operons
L. hordei DSM 19519
KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGTHKC Coagulin (100%)
KYYGNGVSCTKKHGCKVNWGQAFTCSVNRFANFGHGNC Plantaricin 423 (74%)
L. acidipiscis DSM 15836 KYYGNGLHIPKHGKPYINWGQAIQSIGKISYHGWVNGITSGAAGVGRH Hiracin JM79 (44%)
L. futsaii JCM 17355 KYYGNGVSCGKHTCKVNWGQAWNESVNRWGNSWVNGLTGLRQH Plantaricin 423 (57%)
C. maltaromaticum DSM 20722
AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH Carnobacteriocin cbn BM1 (100%)
VYYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP Carnobacteriocin cbn B2 (98%)
(b) Structural Genes for Incomplete Class IIa Operons
L. agilis DSM 20509 SRYYGNGITCGKHKCTVNWGQAWTCGVNRLANFGHGNC Plantaricin 423 (73%)
L. aquaticus DSM 21051 KNYGNGVYCTKKHGYKVDWGQAWSIIGNNSAANSTTRGAAGWKSK Avicin A (74%)
L. rennini DSM 20253 KYYGNGVSCSKHSCSVDWGKALTCTINNGAMAWTTGGHQGNHKC Pediocin Ach/PA-1 (89%)
L. ruminis DSM 20403 KYYGNGVYCGKHKCRVDWGQAWGCSVNRWGAAVGTGGKATIGHC Pediocin Ach/PA-1 (55%)
P. pentosaceus DSM 20336 KYYGNGLYCGKHSCSVDWGKATTCIINNGAMAWATGGHQGTHKC Pediocin Ach/PA-1 (93%)
C. maltaromaticum DSM 20342 AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH Carnobacteriocin cbn BM1 (100%)
Table 4. Structural genes for complete (a) and incomplete (b) Class IIa operons.
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acid identity to pln Sα and the β peptide 48% to pln Sβ. The β peptide found here however lacks the AxxxA motif 
found in pln Sβ, a sequence which has been shown to be important for helix-helix interactions in pln S38.
Another potential two-peptide bacteriocin (acidocin X) was also identified from L. acidophilus DSM 20079. 
Correlation between the bacteriocins identified by BAGEL and the results of MALDI TOF MS led to the identi-
fication of two, bacteriocin like, peptides. The first of these was a 35 amino acid peptide displaying 53% identity 
with the enterocin X β peptide. The second peptide was not identified in BAGEL and was found by manual anal-
ysis of the bacteriocin operon, this displays 25% identity to the enterocin X α peptide.
Bacteriocin Structural Peptide
Gassericin A IYWIADQFGIHLATGTARKLLDAMASGASLGTAFAAILGVTLPAWALAAAGALGATAA
Acidocin B IYWIADQFGIHLATGTARKLLDAVASGASLGTAFAAILGVTLPAWALAAAGALGATAA
Butyrivibriocin AR10 IYFIADKMGIQLAPAWYQDIVNWVSAGGTLTTGFAIIVGVTVPAWIAEAAAAFGIASA
L. paracesei subsp. paracasei 
DSM 5622 (Paracyclicin) IYFIANKLGIHLAPGWYQDMVNYVSAGGSLAGAFSVVAGVTLPAWIVPIATAFGAVSA
L. nodensis DSM 19682
-IWIAGLFGIHLDNSLESKLVSGILNGGSAAGVFAAMLGITLPAWAAAAATAMGATAA
 : ** : ** : * . . : : . : * . : * : : *: * : ** * * * : * . : *
Table 6. Alignment of Class IIc Subgroup II Bacteriocins. * = Positions with a single conserved residue.  
: = Conservation between groups with strongly similar properties, scoring >0.5 in the Gonnet PAM 250 matrix. 
. = Conservation between groups with weakly similar properties, scoring ≤0.5 in the Gonnet PAM 250 matrix.
Species Strain Structural Peptide
L. murinus DSM 20452
YNRLAGQIGHYTGKAVIVGATVLGIASLF Produced 
in vitro (Muricidin)KRGLGYHIVDAVVSFGKGFLDAF
YDIEKALWGGYGYQLGWRNKWNLSHRYFKI
GVPGWYYGMLWKIGVSGYKHRKDIMNGFDRGFNNYPK
L. acidophilus DSM 20079
SNNIFWTRVGVGWAAEARCMIKPSLGNWTTKAVSCGAKGLYAAVRG Produced 
in vitro (Acidocin X)VAPIVYPIAGYVMKQMFEHSDQIIKGFKRGWKKYK
L. taiwanensis DSM 21401
NRWGDTVLSAASGAGTGIKACKSFGPWGMAICGSNRRLFWLYS
RNNWQTNVGGAVGSAMIGATVGGTICGPACAVAGAHYLPILWTGVTAATGGFGKIRK
L. crispatus DSM 20584
NRWTNAYSAALGCAVPGVKYGKKLGGVWGAVIGGVGGAAVCGLAGYVRKG
SKGKGRNNWAGNTIGIVSSAATGAALGSAICGPGCGFVGAHWGAVGWTAVASFSGAFGKIRK
L. nantensis DSM 16982
SFKGFVQGFINGLTGKKH
KGPWNYKTGYNLGKWISKRF
L. apodemi DSM 16634
YDIEKALWKGYGYQLGWRSKWNLSHRYFKI
GVPGWYYSMLWKIGVSGYKHRKDIMSGFDKGFNNYPK
L. plantarum DSM 13273
RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK
GAWKNFWSSLRKGFYDGEAGRAIRR
FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR
VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG
L. plantarum subsp. 
plantarum CGMCC 1.2437
RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK
GAWKNFWSSLRKGFYDGEAGRAIRR
FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR
VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG
L. paraplantarum DSM 10667
FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR
VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG
L. intestinalis DSM 6629
RHSVPYSYGYQSGRGFKGAAAAYNIIKTVASFFE
KRKKHHPWYWSIQEFGRGFLAGLASKYNL
L. rhamnosus DSM 20021
IGPLAIPVAAILGFLATDAWSHADELVAGVKQGWERS
DNGNLWTFIGKAIGSTARSWAEGAMFAPAIGPAKEIVDKLNGN
L. zeae DSM 20178
NAWGNAVNGALNGAATGARFGKNLGPWGMIGGMALGAGIGGYFGYNG
RNTWQQNVSGVAGAAAGGAALGAVVGGPAGAFLGAHYGPILWTAVTGFTGGF
Leuc. fallax KCTC 3537
CPLLPIVVTVAASGAHFVAKDGWNHLDQIRSGWRKSGNSKW
STDGSWEDFGAGLHKTVNTVIYAGTTVARAHTRSHQRCFTGNKW
Table 5. Potential Class IIb Structural Genes.
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Class IIc. Class IIc bacteriocins are also known as circular bacteriocins due to the covalent linkage of the N- 
to C-termini. The compact circular structure of these bacteriocins can contribute to their temperature and pH 
stability39. These circular bacteriocins permeabilize the target cell membrane, resulting in a loss of membrane 
potential which leads to cell death40. Despite having similar modes of action, this class of bacteriocins are fur-
ther broken down into two subgroups, based on the isoelectric point of the peptides and the conservation seen 
amongst the groups41. Currently, there are two examples of class IIc bacteriocins produced from lactobacilli, both 
of which belong to subgroup II. Originally identified as two separate class IIc bacteriocins, Gassericin A (L. gas-
seri LA39) and reutericin 6 (L. reuteri LA6) have now been shown to be identical42, 43. Acidocin B (L. acidophilus 
M46), originally thought to be linear, has also been recently reclassified as a circular bacteriocin. Leuconostoc 
mesenteroides TK41401 has also been shown to produce leucocyclicin Q, a subgroup I circular bacteriocin.
From the analysis carried out in this study, L. paracasei subsp. paracasei DSM 5622 was found to produce a 
potential class IIc bacteriocin (paracyclicin), with a structural gene displaying 64% amino acid identity to butyriv-
ibriocin AR1044. The operon contains a putative ABC permease, ATPase and a protein belonging to the DUF 95 
protein family, all of which have been associated with the gene clusters of circular bacteriocins39. Upon purifi-
cation of the bacterial supernatant, a mass of 5905.75 Da was identified as the causative agent of antimicrobial 
activity. This mass correlates closely with the predicted mass of the mature bacteriocin structural peptide which 
is calculated as 5906.87 Da. It is clear that paracyclicin belongs to the subgroup II circular bacteriocins, due to a 
high level of conservation found within the group (Table 6). Despite this conservation, this novel bacteriocin does 
display variation in certain conserved regions which is not seen in the rest of the class. L. nodensis DSM 19682 
was also found to encode one such potential bacteriocin, however, no antimicrobial activity was observed with 
this strain.
Class IId. Class IId bacteriocins are single peptide, linear bacteriocins which do not display homology to the 
pediocin like bacteriocins4. This class of bacteriocins displays a high degree of diversity and numerous class IId 
bacteriocins have been characterised from lactobacilli previously (Table 1). In silico analysis of the Lactobacillus 
dataset identified numerous novel structural genes (Table 7, Supplementary Table 2) with several shown to be 
produced.
L. paralimentarius DSM 13961 was one such strain to display the production of a class IId bacteriocin (parali-
menterocin). The paralimenterocin structural gene identified encodes a 44 amino acid single peptide bacteriocin 
whose closest homolog appears to be the relatively uncharacterised bacteriocin BacSJ2-8 to which it has 77% 
identity45. The mode of action of both of these bacteriocins remains unclear.
L. equicursoris DSM 19284 is also highly likely to produce a novel class IId bacteriocin (equicursorin). The 
strain displayed antimicrobial production upon analysis, but MALDI TOF MS did not identify an associated 
mass. In silico BAGEL analysis identified three putative bacteriocin operons, two of which encoded larger bacteri-
olysins of approximately 30 kDa, the remaining operon encodes a homolog of lactococcin 972. SDS PAGE analysis 
of the concentrated culture supernatant identified a mass between the 5 kDa and 10 kDa markers which displayed 
antimicrobial activity once overlaid with L. delbrueckii subsp. bulgaricus LMG 6901 (Supplementary Figure 2). 
This mass correlates well with the predicted mass (approximately 7 kDa) of the lactococcin 972 homolog ‘equi-
cursorin’. Lactococcin 972 is unique with respect to its activity in comparison to other class II bacteriocins. These 
bacteriocins do not induce pore formation in the cells but instead act by binding to lipid II and inhibiting septum 
formation. Lactococcin 972 is also unusual in that it’s biologically active form is as a homodimer46, 47. Given that 
only two such bacteriocins have been identified, it was surprising that four further lactococcin 972-like operons 
were identified in the genomic dataset screened in this study (Table 7(b), Supplementary Table 2). An in silico 
screen carried out by Letzel et al.48 identified 9 further Lactococcin 972 operons in anaerobic bacteria, thus due to 
Species Strain Structural Protein
(a) Potential Class IId Structural proteins
L. paralimentarius DSM 13961 NFFGGSNGYSWRDKKGHWHYTVTSGVSSTVAQIIGNGWGSAGAPGVGQR
L. pentosus DSM 20314 KSNTYSLQMGSVVRTATKIFKKMEW
L. hokkaidonensis DSM 26202 VTLSVATHSKNGLKKFFKWVRKL
L. xiangfangensis LMG 26013 KLVKLYTAEPYTFYRDTRTKKIVMRQTTGYSAHLQHVIADGWVRSAHL
L. paracasei DSM 5622 DSIRDVSPTFNKIRRWFDGLFK
L. murinus DSM 20452 YDIEKALWGGYGYQLGWRNKWNLSHRYFKI
Leuc. kimchii IMSNU 11154 KSFWSWASDASSWLSGPQQPNSPLLKKKR
Leuc. geldium KCTC 3527 KRVYIPNGNGAWLDSNTGKGGVDWNVAVPALGSIMVNGWAQNGPLAHLHP
(b) Potential Class IId Lactococcin 972 Homologs
L. equicursoris (equicursorin) DSM 19284 GGTWNYGVGSKYVWSYYSHNSKTHKASVEGKYYVTSGWIKEKTQARASAAKAAAGNQSYYDVK
L. amylophilus DSM 20533 GGTWNYGVGLTGTFGYSDYLHNSKTHSASVGRTKSDCNKVTKTKGVWAQSKYTKIPPTGLNYWWSVS
L. graminis DSM 20719 GGTWYSGFSGTKVYSQYYHGSKKHSATAKNGWGAGVRNTQKAGIWAYSSVNSTLTGNKTYWAVY
L. hamsteri DSM 5661 GGVWNYGVGKKYVWSYYSHHRLTHKSSVEGKYYSSSGWVSPGTEARASAEKAQHGNKSYFDVE
Leuc. argentinum KCTC 3773 GGDWRHGVGSYYVWSYYFHNYRNHSSSVSGQYFASSGRTSPGYDAQASAPKSLFGNKAYYDFW
Table 7. Potential Class IId structural proteins (a) and Class IId lactococcin 972 homologs (b).
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the expansion of this group, these bacteriocins may warrant a separate classification, given their unique mode of 
action when compared to other class II bacteriocins.
Bacteriolysins (Formerly Class III Bacteriocins). In the Lactobacillus dataset, a number of homologs 
of the bacteriolysin helveticin18 were found to be encoded, with several displaying in vitro antimicrobial activity. 
The approximate size of these proteins was determined using SDS PAGE overlay assays, as MALDI TOF MS was 
not used to determine the size of these larger proteins. Several strains encoded numerous helveticin homologs, 
however, SDS PAGE overlays were not able to identify which of these homologs was actually produced as all had 
masses of approximately 37 kDa (Supplementary Figure 3).
L. intestinalis DSM 6629 was shown to produce one of these helveticin homologs, with four potential struc-
tural genes found within the genome ranging from 38% to 67% amino acid identity to helveticin J. L. kitasatonis 
DSM16761 also produced a helveticin like peptide, the strain encodes two such proteins displaying 35% and 
41% identity to helveticin J. Two L. amylovorus strains (DSM 16698 and DSM 20531) were shown to produce a 
helveticin homolog. L amylovovrus DSM 16698 encodes four of such proteins, whilst L. amylovorus DSM 20531 
encodes three. Both share a single identical helveticin homolog but it is unclear whether this is the protein pro-
duced by both strains. L. kalixensis DSM 16043 also produces a helveticin-like protein, with 3 homologs encoded 
within the genome displaying, 34%, 49% and 50% amino acid identity to helveticin J.
BAGEL also identified a helveticin homolog (77% identity to helveticin J) from L. crispatus DSM20584. 
Interestingly, analysis of the results of an exoproteomic study carried out by Johnson et al.49 identified the secre-
tion of this protein previously. The antimicrobial activity of the strain in this study was determined to be due to 
a small peptide by an SDS PAGE overlay assay, this is most likely a lactacin F homolog50 or else a novel TOMM 
like peptide.
Discussion
This study gives the first complete assessment of bacteriocin production across the Lactobacillus Genus Complex, 
combining both in silico and laboratory based screening methods. This combination of approaches allows for a 
more representative estimation of bacteriocin production to be calculated. Well-diffusion assays and MALDI 
TOF MS allows for the confirmation of in vitro bacteriocin production by cells. Bacteriocin production however 
can be a highly regulated process, with strains requiring specific conditions and environments to induce produc-
tion of these antimicrobials51, 52. Such regulations would make it extremely difficult to identify the bacteriocins 
found here using in silico screens if we were to rely on in vitro screening methods alone. Thus, the use of BAGEL 
and BLAST bacteriocin screens allows us to identify these bacteriocin operons from the Lactobacillus Genus 
Complex without the shortcomings and restrictions of laboratory based screens.
In silico analysis has allowed us to determine the overall bacteriocinogenic potential of the Lactobacillus genus. 
Of the 213 strains analysed, 51 were identified by BAGEL or in BLAST screens as harbouring what appears to be 
a complete bacteriocin or helveticin like operon, a prevalence of 23.94%. If we focus on the lactobacilli, of the 175 
strains analysed only 25 were found to encode bacteriocin operons (14%). If helveticin operons and those of pre-
viously characterised bacteriocins are included, of the Lactobacillus species analysed 30% were found to encode 
at least one antimicrobial. This figure of 30% is surprisingly high given that lactobacilli are not associated with the 
production of more traditional antibiotics formed by non-ribosomal peptide synthetases (NRPS) and polyketide 
synthases (PKS). Given the extent of bacteriocin production within the genus, the production of antimicrobials 
by these means may be unnecessary, especially given the size of such NRPS and PKS operons and the subsequent 
energy it would take to produce them. Thus, bacteriocin production may supplant the need for NRPS and PKS 
enzyme complexes in certain genera.
There was a high degree of novelty within the bacteriocins identified by BAGEL in this study and of all the 
structural genes identified, 73% had not previously been characterised. Screening of these strains identified five 
novel functional bacteriocins (muricidin, acidocin X, paracyclicin, paralimenterocin and equicursorin) from a 
range of bacteriocin classes. In addition, five novel producers of helveticin-like peptides were also identified. The 
abundance of homologs of helveticin-like bacteriolysins encoded by lactobacilli is surprising given how little 
these proteins have been characterised to date. The observation that most strains in the L. acidophilus group 
encode helveticins with significant homology suggests that this trait was derived from a common ancestor and 
then disseminated by horizontal transfer. Apart from narrow spectrum antimicrobial activity, no other function 
has been ascribed to these proteins. The role these proteins play in the life cycle of this narrow branch of strains 
warrants further study.
The variety and distribution of bacteriocins throughout the genus is interesting when compared to the results 
of other in silico screens which were carried out. Letzel et al.48 used BAGEL and other tools to screen the genomes 
of 211 anaerobes for bacteriocin encoding genes (no lactobacilli were included in the screen, and helveticin like 
proteins were excluded). Of these 211 strains, just over 25% were found to encode a bacteriocin like peptide. Thus 
despite the differences in the make-up of the datasets, there is a similar level of bacteriocin encoding genes found 
in both groups. While the overall levels may be similar, the diversity of the bacteriocins encoded differs greatly. 
Of the bacteriocins encoded in the anaerobic dataset, 78% were found to be class I modified bacteriocins, while in 
the Lactobacillus Genus Complex this value is only 17%. One similarity between these sets of results, however, is 
the presence of lactococcin 972 like bacteriocins. 9 novel homologs were identified in the anaerobic bacteria, this 
result taken with the number of novel homologs identified from the lactobacilli suggests that this group of unique 
bacteriocins merit their own class of bacteriocins in the future given their unique mode of action and increasing 
prevalence.
In a bioinformatic screen of Bacillus species for bacteriocin operons53, the overall level of bacteriocins encoded 
by such strains was much higher, with 583 putative bacteriocin operons encoded in the genomes of 328 strains. 
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89% of these strains, covering 50 different species encode a bacteriocin, a much higher level than seen in the 
anaerobic bacteria and the lactobacilli. The diversity of encoded bacteriocins again differs to that of the lactoba-
cilli with 66% of operons identified here encoding class I bacteriocins. This difference suggests that there is not 
an even distribution in the types of bacteriocins across genera, with the lactobacilli in particular relying on the 
production of class II bacteriocins in comparison to other groups. A similar high prevalence of bacteriocin oper-
ons can be found in the cyanobacteria, with 145 putative bacteriocin gene clusters being identified in 43 of the 58 
complete and partial genomes screened54. It must be remembered, however, that in both studies these operons 
were not manually analysed so, in reality, overall levels may be lower.
The inter-species diversity of bacteriocin production can be seen in a screen carried out by Liu et al.55 whereby, 
the genomes of 169 Streptococcus mutans strains were screened by BAGEL for bacteriocin operons. 211 bacte-
riocin operons were found distributed amongst 157 strains, of which 32 were lantibiotic operons. These results 
show that despite carrying out a comprehensive analysis of bacteriocin production in lactobacilli, a high level of 
diversity within each species can still result in novel bacteriocins being identified.
The environment from which strains are isolated may also influence their bacteriocinogenic potential. 37.5% 
of strains isolated from human and animal microbiomes encoded bacteriocins or bacteriolysins, this is over twice 
the value for strains isolated from food, wine and beer, plants and the environment at 16.67%. The microbiota 
of animals is a complex community with microbes under constant competition for nutrients and resources56. 
Bacteriocin production can provide a competitive advantage for strains, allowing them to inhibit sensitive strains 
thus reducing competition and allowing them to establish themselves in these environments2, 3, 57. This may sug-
gest why a greater proportion of lactobacilli from these environments encode bacteriocins. Environments such as 
fermented foods would provide a much narrower niche for the growth of microbes. Less competition here may 
negate the need for these bacteria to expend energy on bacteriocin production.
Given the association of lactobacilli with probiotics and food production, the knowledge of their potential to 
produce antimicrobials is of great value58. Bacteriocin production may increase their ability to establish them-
selves in a community such as the gut, or provide a natural mechanism to inhibit the growth of food spoilage 
microorganisms3, 59. Thus bacteriocin production can prove a useful trait for an industrially important group 
of bacteria. Previously, the isolation of bacteriocins from lactobacilli relied on intensive laboratory screens of 
individual cultures. The use of tools such a BAGEL and BLAST however now allow for the rapid identification of 
bacteriocin operons within strains, and with the increasing availability of genomic data, these tools are becoming 
more relevant.
Materials and Methods
Bacteriocin Identification. The bacteriocin mining tool BAGEL2 was used to identify putative bacteri-
ocin operons10 and the genome visualisation tool ARTEMIS was subsequently used for manual analysis of the 
bacterial genomes60. To determine the degree of novelty in the bacteriocins identified by BAGEL2, BLASTP 
searches were done for each putative bacteriocin peptide against those identified in the BAGEL screen. The lev-
els of identity described in this study are derived from Clustal Omega. For bacteriocin analysis using specific 
“driver” sequences, the BLASTP program was used using default parameters. The driver sequences used were 
NisC (GenBank Accession no. CAA79470.1), LtnM1 (GenBank Accession no. NP_047321.1), VenL (GenBank 
Accession no. AEA03262.1), TrnC and TrnD from Bacillus thuringiensis DPC 6431.
Bacterial strains. The bacterial strains screened for bacteriocin production and the conditions for growth 
are listed in Supplementary Table 3. Anaerocult A gas packs (Merck, Darmstadt, Germany) were used to generate 
anaerobic conditions.
Bacteriocin Assays. Bacteriocin activity was analysed via well diffusion assays against the indicator organ-
isms listed in Supplementary Table 4. Briefly, each strain screened was grown in broth under the appropriate 
conditions. The cell free supernatant of each culture was prepared by centrifugation of the fully grown culture at 
4000 RCF for 20 minutes, the pH was adjusted to pH 7 using sodium hydroxide to negate any antimicrobial activ-
ity which may be caused by the acidity of the cell free supernatants. 50 μl of an overnight culture of each indicator 
was then added to 20 ml of the appropriate media containing 1.5% agar. Plates were allowed cool and the 7 mm 
wide wells were bored into the agar. 50 μl of the cell free supernatant of the strains being tested was then placed in 
a well. These indicator plates were refrigerated for two hours prior to incubation.
Mass Spectrometry (MS). MALDI TOF colony mass spectroscopy was carried out on each of the strains 
as described by Field et al.61 to identify masses of putative bacteriocins. Here colonies were first mixed with a 
70% propan-2-ol 0.1% TFA solution to elute bacteriocin from the cell. Following centrifugation, the subsequent 
supernatant was spotted on the target pre-coated with CHCA matrix solution. A further layer of matrix solution 
was then added on top of this supernatant. An Axima TOF2 MALDI TOF mass spectrometer (Shimadzu Biotech, 
Manchester, UK) was used to identify the peptide masses using positive-ion reflectron mode.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE). SDS PAGE was used 
for the identification of higher molecular weight antimicrobial proteins (bacteriolysins). Cultures were grown 
overnight in broth and the cell free supernatants were prepared as described above. The proteins from the bac-
terial supernatant were precipitated by the addition of ammonium sulphate salts up to a concentration of 50%. 
The precipitate was collected by centrifugation and resuspended in water. Supernatants were then incubated with 
TruPAGETM LDS sample buffer (Sigma-Aldrich, Wicklow, Ireland) for 10 minutes at 70°C. Samples were run on 
12% acrylamide gels at 30 mA, together with Precision Plus Protein™ Dual Xtra prestained protein standards 
(Bio-Rad, Hertfordshire, UK) which were used to estimate molecular mass with a range of 2–250 kDa. The com-
pleted gels were divided in two, one half was stained using the EZBlueTM staining reagent (Sigma-Aldrich). The 
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other half was washed with 1% tween-80 (Sigma-Aldrich) for 45 minutes, followed by three 5 minute washes in 
distilled water. This gel was overlaid with soft MRS agar (0.8% agar), seeded with 0.25% of an overnight culture 
of L. delbrueckii subsp. bulgaricus LMG 6901. The plate was incubated overnight to determine the mass of any 
antimicrobial proteins produced.
Bacteriocin Purification. Carnobacteriocins CbnB2, CbnBM1 and CbnX. Carnobacterium maltaromati-
cum DSM 20722 was grown overnight in TSA broth, 100 ml of the supernatant was passed through a 5 g, 20 ml 
Strata C18-E solid-phase extraction (SPE) column (Phenomenex, Cheshire, UK). The column was washed with 
20 ml of 30% ethanol and 20 ml of 70% 2-propanol (IPA) 0.1% TFA. The 70% IPA eluent was concentrated and 
applied to a Semi Prep Proteo Jupiter RP-HPLC column (10 × 250 mm, 90 Å, 4 µ) (Phenomenex, Cheshire, UK) 
running a 20–55% gradient whereby buffer B was 90% acetonitrile. MALDI TOF MS was carried out on fractions 
to identify the presence of the peptides of interest.
Paracyclicin. L. paracasei subsp. paracasei DSM 5622 was grown overnight in MRS broth. Culture supernatant 
was passed through a column containing 60 g Amberlite XAD beads and washed with 400 ml of 50% ethanol and 
the antimicrobial peptide eluted with 400 ml of 70% IPA 0.1% TFA. The IPA was removed and the eluent passed 
through a 5 g, 20 ml C18 SPE column pre-equilibrated with methanol and water. The column was washed with 
30 ml of 50% ethanol and activity eluted with 30 ml of IPA. The IPA was removed from the C18 SPE IPA eluent 
and the sample applied to a semi preparative Vydac C4 Mass Spec (10 × 250 mm, 300 Å, 5 µ) RP-HPLC column 
(Grace, Columbia, USA) running an acetonitrile and propan-2-ol gradient described as follows: 5–55% buffer B 
and 0–5% buffer C over 25 minutes followed by and 55–19% buffer B and 5–81% buffer C over 60 minutes, 19–5% 
buffer B and 81–95% buffer C over 5 minutes where buffer A is Milli Q water containing 0.1% TFA, buffer B is 
90% acetonitrile 0.1% TFA and buffer C is 90% propan-2-ol 0.1% TFA. Eluent was monitored at 214 nm and frac-
tions were collected at 1 minute intervals. Fractions were assayed using well diffusion assays against L. delbrueckii 
subsp. bulgaricus LMG 6901. MALDI TOF MS was used to determine the mass of the antimicrobial peptide.
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